Qube Research & Technologies LTD Oric Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$6.63 - $12.93 $186,859 - $364,419	28,184 Added 53.13%	81,227 $574,000
Q1 2024 May 14, 2024	BUY	$8.04 - $16.03 $426,465 - $850,279	53,043 New	53,043 $729,000
Q1 2023 May 15, 2023	BUY	$4.26 - $6.75 $118,334 - $187,501	27,778 Added 69.99%	67,466 $384,000
Q4 2022 Feb 14, 2023	BUY	$2.41 - $5.89 $33,807 - $82,624	14,028 Added 54.67%	39,688 $233,000
Q3 2022 Nov 14, 2022	SELL	$3.15 - $5.24 $16,987 - $28,259	-5,393 Reduced 17.37%	25,660 $82,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.07 $83,843 - $219,544	31,053 New	31,053 $139,000
Q3 2021 Nov 12, 2021	SELL	$15.9 - $25.22 $357,940 - $567,752	-22,512 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$17.37 - $25.34 $391,033 - $570,454	22,512 New	22,512 $398,000

124

66.6M

7.8K

700

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $336M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.